AstraZeneca Selects 吃瓜爆料 Vault Quality Suite to Modernize Global Quality Management

AstraZeneca Selects 吃瓜爆料 Vault Quality Suite
to Modernize Global Quality Management

Leading biopharmaceutical company to unify quality management and content
to increase operational efficiency and agility

PLEASANTON, CA — Sept. 15, 2020 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that AstraZeneca has selected 吃瓜爆料 Vault QMS and 吃瓜爆料 Vault QualityDocs to unify quality management and content on a single cloud platform. 吃瓜爆料 Vault Quality Suite enables AstraZeneca to streamline quality processes across the enterprise, increasing real-time visibility, efficiency, and speed.

"As AstraZeneca builds on a strong foundation for world-class quality systems and processes,” said Anthony Morandi, vice president of quality at AstraZeneca. “吃瓜爆料 Vault Quality Suite will provide us with a standardized, scalable, efficient, and compliant approach to managing our global quality systems and continued growth."

Driving manufacturing agility through automation is foundational to AstraZeneca’s strategic digital transformation initiative. With the Vault Quality Suite, AstraZeneca can easily collaborate with external suppliers and partners to increase transparency and bring drugs to patients faster.

"We are pleased to partner with AstraZeneca to help enable end-to-end quality management," said Mike Jovanis, vice president of Vault Quality at 吃瓜爆料. "We are looking forward to continuing to help AstraZeneca streamline quality processes and drive greater agility."

Learn how life sciences companies are modernizing quality management with the Vault Quality Suite at the upcoming 吃瓜爆料 R&D & Quality Summit, October 13-14, 2020. The online event is open to life sciences industry professionals. Register and view the agenda at veeva.com/Summit.

Additional Information
For more on 吃瓜爆料 Vault Quality Suite, visit: veeva.com/Quality
Connect with 吃瓜爆料 on LinkedIn:
Follow @veevasystems on Twitter:
Like 吃瓜爆料 on Facebook:

About AstraZeneca
AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit and follow the Company on Twitter .

About 吃瓜爆料 Systems
吃瓜爆料 Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 900 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. 吃瓜爆料 is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of 吃瓜爆料’s products and services, the results from use of 吃瓜爆料’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon 吃瓜爆料’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent 吃瓜爆料’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and 吃瓜爆料 disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect 吃瓜爆料’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at . Further information on potential risks that could affect actual results will be included in other filings 吃瓜爆料 makes with the SEC from time to time.

###

Contact:

吃瓜爆料 Systems
pr@veeva.com

Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com